Learn More
BACKGROUND Biologic drug survival in psoriasis reflects long-term performance in real-life settings. Previous studies have yielded inconsistent results. OBJECTIVES We sought to analyze long-term(More)
BACKGROUND Differences in response rates of biologics for the treatment of moderate-to-severe plaque psoriasis have been reported in several meta-analyses published to date. However, the usefulness(More)
BACKGROUND Both the safety and efficacy of biologic therapy may be affected in the presence of highly prevalent chronic viral hepatitis. OBJECTIVE To evaluate the safety and effectiveness of(More)